Non-motor fluctuations in Parkinson's disease;Les fluctuations non motrices de la maladie de Parkinson

Revue Neurologique

Volumn 163, Issue 8-9, 2007, Pages 846-850

  Witjas, T ^a   Kaphan, E ^a   Azulay, J P ^a  

^a TIMONE HOSPITAL   (France)

Author keywords

Assessment scales; Nonmotor fluctuations; Nonmotor symptoms; Parkinson's disease

Indexed keywords

APOMORPHINE; CATECHOLAMINE DERIVATIVE; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; METHYLTRANSFERASE INHIBITOR;

ABDOMINAL PAIN; ADRENERGIC SYSTEM; BRAIN DEPTH STIMULATION; CARDIOVASCULAR SYMPTOM; COGNITIVE DEFECT; DISEASE CLASSIFICATION; DOPAMINERGIC SYSTEM; DYSAUTONOMIA; DYSPNEA; GASTROINTESTINAL SYMPTOM; HUMAN; MENTAL DISEASE; NEUROLOGIC DISEASE; NEUROMODULATION; NONMOTOR FLUCTUATION; PAIN; PARKINSON DISEASE; PATHOGENESIS; PATHOPHYSIOLOGY; RECOGNITION; REVIEW; SENSORY DYSFUNCTION; SEROTONINERGIC SYSTEM; SUBTHALAMIC NUCLEUS; THORAX PAIN;

EID: 34548674249     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-3787(07)91470-8     Document Type: Short Survey

References (38)

1. AZULAY JP, DURIF F, ROGEZ R, TRANCHANT C, BOURDEIX I, RERAT K. (2005). Precoce survey: a new self-assessment patient card to early detection and management of Parkinson's disease fluctuations. Mov Disord, 20: 399.
2. AZULAY JP, WITJAS T, RÉGIS J et al. (2007). Effet de la stimulation du noyau sous-thalamique sur les conduites addictives dans la maladie de Parkinson. Rev Neurol (Paris), 163 : 1S41-1S43.
3. BALL B. (1882). De l'insanité dans la paralysie agitante. L'encéphale, 2 : 22-32.
4. BARATTI M, CALZETTI S. (1984). Fluctuation of arterial blood pressure during end-of-dose akinesia in Parkinson's disease. J Neurol Neurosurg Psychiatry, 47: 1241-1243.
5. BLACK KJ, HERSHEY T, HARTLEIN JM, CARL JL, PERLMUTTER JS. (2005). Levodopa challenge neuroimaging of levodopa-related mood fluctuations in Parkinson's disease. Neuropsychopharmacology, 30: 590-601.
6. BROWN RD, MARSDEN CD, QUINN N, WYKE MA. (1984). Alterations in cognitive performance and affect arousal state during fluctuations in motor function in Parkinson's disease. J Neurol Neurosurg Psychiatry, 47: 454-465.
7. CANTELLO R, GILLI M, RICCIO A, BERGAMASO B. (1986). Mood changes associated with "end of dose deterioration" in Parkinson's disease. J Neurol Neurosurg Psychiatry, 49: 1182-1190.
8. CHAUDHURI KR, MARTINEZ-MARTIN P, SHAPIRA AHV et al. (2004). International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson'disease: the NMS-Quest study. Mov Disord, 21: 916-923.
9. FÉNELON G, MAHIEUX F, HUON R, ZIEGLER M. (2000). Hallucinations in Parkinson's disease. Prevalence, phenomenology and risk factors. Brain, 123: 733-745.
10. FERNANDEZ W, STERN G. (1992). Hallucinations and parkinsonian motor fluctuations. Behav Neurol, 5: 83-86.
11. GIUFFRIDA R, VINGERHOETS FJG, BOGOUSSLAVSKY J, GHIKA J. (2005). Syndromes douloureux de la maladie de Parkinson. Rev Neurol (Paris), 161: 407-418.
12. GOETZ CG, LUTGE W, TANNER CM. (1986) Autonomic dysfunction in Parkinson's disease. Neurology, 36: 73-75.
13. GOETZ CG, TANNER CM, LEVY M, WILSON RS, GARRON DC. (1986) Pain in Parkinson's disease. Mov Disord, 1: 45-49.
14. GUNAL DI, NURICHALICHI K, TUNCER N, BEKIROGLU N, AKTAN S. (2002). The clinical profile of nonmotor fluctuations in Parkinson's disease patients. Can J Neurol Sci, 29: 61-64.
15. HILLEN ME, SAGE JI. (1996). Non-motor fluctuations in patients with Parkinson's disease. Neurology, 47: 1180-1183.
16. KARLSEN K, LARSEN JP, TANDBERG E, JORGENSEN K. (1999). Fatigue in patients with Parkinson's disease. Mov Disord, 14: 237-241.
17. KOLLER WC. (1984). Sensory symptoms in Parkinson's disease. Neurology, 34: 957-959.
18. LANG AE, JOHNSON K. (1987). Akathisia in idiopathic Parkinson's disease. Neurology, 37: 477-481.
19. LOU JS, KEARNS G, BENICE T et al. (2003). Levodopa improves physical fatigue in Parkinson's disease: a double-blind, placebo-controlled, crossover study. Mov Disord, 18: 1108-14.
20. MARICLE RA, NUTT JG, VALENTINE RJ, CARTER JH. (1995). Dose-response relationship of levodopa with mood and anxiety in fluctuating Parkinson's disease: a double-blind, placebo controlled study. Neurology, 45: 1757-1760.
21. MARICLE RA, VALENTINE RJ, CARTER JH, NUTT JG. (1998). Mood response to levodopa infusion in early Parkinson's disease. Neurology, 50: 1890-1892.
22. MARSDEN CD, PARKES JD. (1976). "On-off" effects in patients with Parkinson's disease on chronic levodopa therapy. Lancet, 1(7954): 292-296.
23. MENZA MA, SAGE J, MARSHALL E, CODY R, DUVOISIN R. (1990). Mood changes and "on-off" phenomena in Parkinson's disease. Mov Disord, 5: 148-151.
24. OKUN MS, WALTER BL, MCDONALD WM et al. (2002). Beneficial effects of testosterone replacement for the nonmotor symptoms of Parkinson disease. Arch Neurol, 59: 1750-1753.
25. POEWE W, BERGER W, BENKE W, SCHELOSKY L. (1991). High-speed memory scanning in Parkinson's disease: adverse effects of levodopa. Ann Neurol, 29: 670-673.
26. QUINN NP, KOLLER WC, LANG AE, MARSDEN CD. (1986). Painful Parkinson's disease. Lancet, 1: 1366-1369.
27. RACETTE BA, HARTLEIN JM, HERSHEY T, MINK JW, PERLMUTTER JS, BLACK KJ. (2002). Clinical features and comorbidity of mood fluctuations in Parkinson's disease. J Neuropsychiatry Clin Neurosci, 14: 438-442.
28. RAUDINO F. (2001). Non motor off in Parkinson's disease. Acta Neurologica Scandinavica, 104: 312-315.
29. RÉMY P, DODER M, LEES A, TURJANSKI N, BROOKS D. (2005). Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain, 128: 1314-1322.
30. RICHARD IH, JUSTUS AW, KURLAN R. (2004). Relationship between mood and motor fluctuations in Parkinson's disease. J Neuropsychiatry Clin Neurosci, 13: 35-41.
31. RILEY DE, LANG AE. (1993). The spectrum of levodopa-related fluctuations in Parkinson's disease. Neurology, 43: 1459-1464.
32. SAGE JI, MARK MH. (1995). Drenching sweats as an "off" phenomenon in Parkinson's disease: treatment and relation to plasma levodopa profile. Ann Neurol, 37: 120-122.
33. SCHOLTISSEN B, VERHEY FR, STEINBUSCH HW, LEENTJENS AF. (2006). Serotoninergic mechanisms in Parkinson's disease: opposing results from preclinical and clinical data. J Neural Transm, 113: 59-73.
34. STACY M, BOWRON A GUTTMAN M et al. (2005). Identification of motor and nonmotor wearing-off in Parkinson's disease: comparison of a patient questionnaire versus a clinician assessment. Mov Disord, 20: 726-733.
35. SWINN L, SCHRAG A, VISWANATHAN R, BLOEM BR, LEES A, QUINN N. (2003). Sweating dysfunction in Parkinson's disease. Mov Disord, 18: 1459-1463.
36. VAZQUEZ A, JIMENEZ-JIMENEZ FJ, GARCIA-RUIZ P, GARCIA-URRA D. (1993). "Panic attacks" in Parkinson's disease. A long-term complication of levodopa therapy. Arch Neurol, 87: 14-18.
37. WITJAS T, KAPHAN E, AZULAY JP et al. (2002). Nonmotor fluctuations in Parkinson's disease: frequent and disabling. Neurology, 59: 408-413.
38. WITJAS T, KAPHAN E, RÉGIS J, JOUVE E, ALI CHÉRIF A, PÉRAGUT JC, AZULAY JP. (2007). Effects of chronic subthalamic stimulation on nonmotor fluctuations in Parkinson's disease. Mov Disord, Epub ahead of print.